Edited by Tanja D. de Gruijl, PhD and Howard Kaufman, MD, FACS
While local immunotherapy has the potential to deliver high doses of immune potentiating agents with limited systemic toxicity, clinical development and implementation have been hindered by numerous challenges. This special series addresses the potential promise of local immunotherapy and provides guidance on how to overcome current challenges in local drug development.
Authored by leading experts, “The Role of Local Immunotherapy in the Treatment of Cancer” covers various aspects of local immunotherapy and expands upon the topics and concepts presented in the SITC “Summit on Intralesional Immunotherapy: Moving Beyond Oncolytic Viruses” held in September 2024. This series aims to define and reorient the field to fully realize the potential promise of local immunotherapy.
View the first publication below. Check back throughout 2026 for additional articles.